Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

abnormal behavior 1 | 226
abnormal gait 1 | 51
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating chloride... 1 | 32
decreased lean body mass 1 | 195
decreased leukocyte cell numbe... 1 | 54
decreased spleen weight 1 | 13
enlarged liver 1 | 3
hypoactivity 1 | 89
increased circulating HDL chol... 1 | 63
increased circulating alanine ... 1 | 11
increased circulating alkaline... 1 | 119
increased circulating aspartat... 1 | 17
increased circulating calcium ... 1 | 32
increased circulating choleste... 1 | 53
increased circulating fructosa... 1 | 11
increased circulating glucose ... 1 | 16
increased circulating iron lev... 1 | 25
increased circulating phosphat... 1 | 24
increased circulating potassiu... 1 | 31
increased circulating serum al... 1 | 25
increased circulating total pr... 1 | 20
increased hematocrit 1 | 36
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased total body fat amoun... 1 | 57
lethargy 1 | 5
small seminal vesicle 1 | 6
thrombocytopenia 1 | 46
tremors 1 | 34

Disease

Cancer 5 | 2,346
Obesity 5 | 616
diabetes mellitus 5 | 1,663
Arthritis 4 | 248
Asthma 4 | 349
Hypertension 4 | 287
Kidney disease 4 | 396
breast carcinoma 4 | 1,614
ovarian cancer 4 | 8,484
psoriasis 4 | 6,685
Anorexia nervosa 3 | 59
Atopic dermatitis 3 | 944
Autistic Disorder 3 | 320
Heart disease 3 | 279
Hyperglycemia 3 | 120
Hyperinsulinism 3 | 63
Hypertensive disease 3 | 193
Hypogonadism 3 | 70
Infertility 3 | 163
Inflammatory bowel disease 3 | 142
Liver disease 3 | 219
Mammary Neoplasms 3 | 410
Metabolic syndrome X 3 | 155
Schizophrenia 3 | 501
adult high grade glioma 3 | 2,148
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 499
invasive ductal carcinoma 3 | 2,950
pituitary cancer 3 | 1,972
Alcohol dependence 2 | 107
Allergic hypersensitivity disease 2 | 123
Alzheimer's disease 2 | 644
Amenorrhea 2 | 60
Anovulation 2 | 20
Anxiety disorder 2 | 22
Arthritis, Experimental 2 | 39
Atherosclerosis 2 | 275
Breast cancer 2 | 3,094
Carcinoma 2 | 2,147
Cardiomegaly 2 | 66
Cardiomyopathies 2 | 90
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Colonic Neoplasms 2 | 126
Crohn Disease 2 | 97
Dermatitis 2 | 107
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Epilepsy 2 | 346
Eye disease 2 | 55
Fatty Liver 2 | 48
Fatty liver disease 2 | 84
Female infertility 2 | 28
Fibrosis 2 | 40
Gestational Diabetes 2 | 17
Heroin dependence 2 | 30
Hyperandrogenism 2 | 32
Hyperphagia 2 | 4
Hypersensitivity reaction type II disease 2 | 235
Hyperthyroidism 2 | 50
Hypothyroidism 2 | 89
Inflammation 2 | 109
Insulin Resistance 2 | 48
Kidney Diseases 2 | 86
Klinefelter's syndrome 2 | 59
Liver Cirrhosis, Experimental 2 | 108
Major Depressive Disorder 2 | 106
Migraine 2 | 79
Multiple Sclerosis 2 | 498
Neuropathy 2 | 210
Obesity, Morbid 2 | 6
Osteoporosis 2 | 257
Pain agnosia 2 | 99
Pancreatic Diseases 2 | 6
Pneumonia 2 | 133
Polycystic Ovary Syndrome 2 | 332
Prostatic Neoplasms 2 | 471
Proteinuria 2 | 63
Seizures 2 | 95
Weight Gain 2 | 87
Withdrawal disorder 2 | 19
atypical teratoid / rhabdoid tumor 2 | 4,369
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
glioblastoma 2 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
medulloblastoma 2 | 1,524
osteosarcoma 2 | 7,933
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pilocytic astrocytoma 2 | 3,086
tuberculosis 2 | 1,557
Facial paralysis 1 | 15
Hepatomegaly 1 | 10
Hyperprolactinemia 1 | 22
Neurodegenerative Disorders 1 | 37
Polycystic liver disease 1 | 10
Substance abuse 1 | 55
Thyroiditis 1 | 25

Tissue

Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Nervous System 6 | 18,561
Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Ion Channel 1 | 341
Transcription Factor 1 | 1,400

Grant Application

5R01DK059903-03 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Leptin receptor LEPR Tclin Non-IDG -2.98449 751.7 530
Pro-opiomelanocortin POMC Tbio Non-IDG -4.54944 36028.8 1100
Signal transducer and activator of transcription 3 STAT3 Tchem Transcription Factor -3.71636 5706.6 1539
Polycystin-2 PKD2 Tbio Ion Channel -2.65714 491.3 218
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796